Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001689375-26-000036

Options or other derivatives

  • Director acquired 19,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Thistle Mary Director 2026-06-10 Grant or award · Stock Option (Right to Buy) +19,000 19,000 D: show line 1 in the form
Loading xslF345X06/wk-form4_1781298072.xml…